STAT

MARCH 6, 2024

WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug price negotiation program and will preview the plan in his State of the Union address, the White House announced Wednesday.

Drug Pricing 357

Drug Pricing 357

STAT

JANUARY 18, 2024

WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the CEOs of Johnson & Johnson and Merck related to an investigation into high drug prices in the United States, he announced Thursday. Read the rest…

Drug Pricing 357

Drug Pricing 357

STAT

OCTOBER 29, 2024

The historic Inflation Reduction Act of 2022 has fundamentally improved the affordability of and access to prescription drugs for millions of people with Medicare. The law laid out aggressive timelines for implementing the Medicare Drug Price Negotiation Program.

Drug Pricing 215

Drug Pricing 215

STAT

JULY 15, 2024

Medicare’s new guidelines cover how it will conduct the drug price negotiations authorized by the Inflation Reduction Act. It will also deter companies from doing research on existing medicines to create improved versions that are more effective and have fewer side effects.

Drug Pricing 303

Drug Pricing Hospitals 303

STAT

JANUARY 25, 2024

Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional staff that he didn’t have the expertise to testify at a Senate hearing on prescription drug prices because he’s a tax attorney.

Drug Pricing 363

Drug Pricing 363

STAT

JANUARY 31, 2024

— Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. WILMINGTON, Del. It didn’t go well for them.

Drug Pricing 363

Drug Pricing 363

STAT

MARCH 1, 2024

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program. Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments.

Drug Pricing 294

Drug Pricing 294

STAT

FEBRUARY 1, 2024

WASHINGTON  — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

Drug Pricing 317

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 317

STAT

MAY 8, 2023

EQRx, a company that aimed to lower drug prices by introducing inexpensive me-too medicines, said Tuesday that it has abandoned that plan and is laying off nearly 60% of its workforce. Continue to STAT+ to read the full story…

Drug Pricing 333

Drug Pricing Hospitals 333

STAT

MAY 6, 2024

The changing landscape of drug pricing policy in the U.S. Drug policy changes are being influenced by perceptions of the value of novel medicines relative to their budgetary impacts, with some believing that many medicines may not be worth their cost, creating an important role for health technology assessments (HTA).

Drug Pricing 359

Drug Pricing 359

STAT

FEBRUARY 1, 2024

So my enterprising colleague John Wilkerson trekked up to Wilmington to give you an inside view on how a key judge viewed arguments in the first court test of the new Medicare drug price negotiation program. Read the rest…

Drug Pricing 255

Drug Pricing 255

STAT

FEBRUARY 8, 2024

Bernie Sanders’ prescription drug pricing theater. WASHINGTON — Call it Sen. The hearing, featuring Merck CEO Robert Davis, Johnson and Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked.

Drug Pricing 310

Drug Pricing 310

STAT

AUGUST 24, 2023

At the start and halfway points of each year, many pharmaceutical companies raise drug prices to bolster revenue and reportedly fund new research. “It’s not just all selling new drugs,” said Juliette Cubanski, deputy director of the Program on Medicare Policy at Kaiser Family Foundation.

Drug Pricing 246

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 246

Drug Patent Watch

OCTOBER 1, 2024

In the world of healthcare, few topics spark as much debate and confusion as prescription drug pricing. Let’s dive into the intricate world of pharmaceutical economics and uncover the factors that determine the price tags on our prescriptions.

Drug Pricing 101

Drug Pricing 101

STAT

FEBRUARY 8, 2024

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Drug Pricing 316

Drug Pricing Diabetes 316

STAT

SEPTEMBER 8, 2022

The passage of the Inflation Reduction Act brings a new era to drug pricing in the United States. After decades of being an outlier, it now joins every other developed nation in having the federal government engaged in negotiating drug pricing.

Drug Pricing 253

Drug Pricing 253

STAT

MARCH 9, 2023

WASHINGTON — President Biden made lowering drug prices a key part of his budget with proposals to expand Medicare drug price negotiation, squeeze more rebates out of drug companies, and lower the cost of insulin for everyone with insurance. The request made Thursday also details a $7.2

Drug Pricing 246

Drug Pricing 246

STAT

DECEMBER 6, 2023

judge ruled that Minnesota must temporarily halt a controversial law that is designed to provide transparency into prescription drug pricing over concerns that it is unconstitutional. In a victory for the pharmaceutical industry, a U.S.

Drug Pricing 313

Drug Pricing Pharmaceutical Manufacturing 313

STAT

AUGUST 15, 2024

Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and recent publication retractions pull down the entire psychedelics industry? And what would you name a commercial psychotherapy treatment? We discuss all that and more on this week’s episode of “The Readout LOUD.”

Drug Pricing 272

Drug Pricing 272

pharmaphorum

SEPTEMBER 18, 2024

PBM Express Scripts has sued the FTC, claiming its recent report on the sector's role in drug pricing is defamatory and should be retracted

Drug Pricing 122

Drug Pricing 122

pharmaphorum

SEPTEMBER 12, 2024

Explore the ins and outs of Medicare drug pricing negotiations with Alice Valder Curran on this insightful podcast. Learn more about what comes next in this crucial healthcare sector.

Drug Pricing 98

Drug Pricing 98

PharmaVoice

AUGUST 18, 2022

Now that Medicare will be able to negotiate drug prices under the Inflation Reduction Act, the industry can expect to see some changes. Here are some tips on how to navigate the changing tide.

Drug Pricing 262

Drug Pricing 262

STAT

OCTOBER 17, 2024

Hello, and happy Thursday from Boston at the STAT Summit ! For those of you following along virtually, my co-author Sarah Owermohle is interviewing Atul Gawande, the assistant administrator of global health at USAID, this afternoon, and Bob Herman is interviewing former CMS administrator Don Berwick about the future of Medicare.

Drug Pricing 251

Drug Pricing 251

STAT

MAY 11, 2023

is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices. Chairman Bernie Sanders (I-Vt.)

Drug Pricing 284

Drug Pricing Packaging 284

STAT

AUGUST 15, 2023

As STAT reported recently, the Senate Committee on Health, Education, Labor, and Pensions (HELP) has indicated that it will not consider the nomination of Monica Bertagnolli as director of the National Institutes of Health unless she pledges to take specific steps to reduce drug prices. Read the rest…

Drug Pricing 246

Drug Pricing 246

STAT

MAY 24, 2023

The goal is to give states more leverage in price negotiations by forcing drugmakers to share and publish details about their pricing data. The government would collect specific drug pricing information from makers of up to 10 particularly high-cost drugs.

Drug Pricing 246

Drug Pricing 246

pharmaphorum

AUGUST 16, 2024

Joe Biden and Kamala Harris reaffirm commitment to Medicare drug pricing negotiations in first joint rally since ticket swap.

Drug Pricing 113

Drug Pricing 113

STAT

MARCH 8, 2023

WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive program will start to negotiate drug prices — let alone the substantive ones, Medicare chief Meena Seshamani said at a STAT event Tuesday.

Drug Pricing 246

Drug Pricing 246

STAT

OCTOBER 2, 2023

… A federal court judge allowed the new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional , STAT reports. Meanwhile, Novo Nordisk became the latest pharmaceutical company to file a lawsuit against the Medicare drug price negotiation program , Bloomberg Law tells us. The

Drug Pricing 260

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 260

STAT

JULY 26, 2023

They’re focused this summer on reining in pharmacy middlemen to make the system fairer — but none of their many proposals will actually tackle the core dynamic that has incentivized higher drug prices. There are major packages on so-called PBM reform percolating in at least six different congressional committees.

Drug Pricing 246

Drug Pricing Packaging Pharmaceutical Companies Pharmaceutical Companies 246

PharmaVoice

AUGUST 31, 2023

Medicare just announced its first-ever drug price negotiations and legislators are quickly pushing to broaden the program.

Drug Pricing 147

Drug Pricing 147

STAT

JANUARY 23, 2024

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at some polarizing cancer data, a strange CEO transition, and the importance of New Year cheer. Read the rest…

Drug Pricing 241

Drug Pricing Drug Development 241

STAT

AUGUST 20, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.    Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Hello and happy Tuesday!

Drug Pricing 284

Drug Pricing Hospitals 284

STAT

DECEMBER 1, 2022

At a time when many Americans are clamoring for more transparency into prescription drug pricing, one key provider of that data is making it harder to access the information.

Drug Pricing 246

Drug Pricing Packaging 246

STAT

NOVEMBER 2, 2023

WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy middlemen and ensure patients aren’t paying more than insurers do for medications. The package crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) is slated to be marked up on Nov.

Packaging 352

Packaging Drug Pricing 352

STAT

MARCH 10, 2023

By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products.

Drug Pricing 246

Drug Pricing 246

Drug Channels

MARCH 6, 2023

Experts from across the industry will discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to March 31, 2023.*

Drug Pricing 98

Drug Pricing 98